1 option
Endoscopic ultrasound for the diagnosis of disease and staging of cancers in adult patients with gastroenterological or oncological disease : a review of the clinical effectiveness, cost-effectiveness and safety / prepared by Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Government document
- Series:
- Rapid response report (Canadian Agency for Drugs and Technologies in Health).
- NCBI Bookshelf.
- Rapid response report: summary with critical appraisal 1922-8147
- NCBI Bookshelf
- Language:
- English
- Subjects (All):
- Endosonography.
- Gastrointestinal Diseases--diagnostic imaging.
- Neoplasms--diagnostic imaging.
- Neoplasm Staging.
- Treatment Outcome.
- Cost-Benefit Analysis.
- Medical Subjects:
- Endosonography.
- Gastrointestinal Diseases--diagnostic imaging.
- Neoplasms--diagnostic imaging.
- Neoplasm Staging.
- Treatment Outcome.
- Cost-Benefit Analysis.
- Physical Description:
- 1 online resource (1 PDF file (23 pages)) : illustration.
- Other Title:
- Endoscopic ultrasound for disease diagnosis and cancer staging.
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 18 March 2014.
- Summary:
- Identification of cancers and gastroenterological diseases can be challenging, as clinicians must ensure the process for identification is accurate while minimizing complications and ensuring sustainability associated with procedures. In addition, for those with cancer, accurate staging is vital for guiding the most appropriate therapy. There are a number of minimally invasive imaging strategies that may be used for identifying and staging different types of cancers, as well as identifying gastroentological disease. Examples of imaging strategies include computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), endoscopic retrograde cholangiopancreatography (ERCP), and endoscopic ultrasound (EUS). Each strategy is associated with differing accuracy for different diseases, as well as when comparing diagnosis and staging of illness. In addition, each strategy is associated with other benefits and limitations. For example, EUS is often less expensive and more readily available relative to other imaging modalities like CT, PET and MRI, but CT, PET and MRI allow for visualization of a larger area compared with EUS. Also, the amount of radiation exposure, and need for contrast media, differs between each modality. Lastly, these imaging modalities may be complementary to one another, for example, using EUS to minimize exposure to the more invasive ERCP in people with acute biliary pancreatitis. The purpose of this review was to evaluate the evidence for clinical effectiveness, safety, and cost effectiveness of EUS compared to other imaging modalities including CT, MRI, PET, or ERCP.
- Notes:
- "CADTH rapid response service."
- Description based on version viewed April 17, 2015.
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.